Rhoshan Pharmaceuticals, Inc.

Amendment
CIK: 0001756479·Pharmaceuticals·DELAWARE·Filed: Jul 22, 2026
Total Offering

$3,158,776

Amount Sold

$3,099,969

Investors

4

First Sale

Sep 18, 2023

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Hitha Palepu
Nagesh Palepu
Allan Clarke
Charlene Messinger

Company

Rhoshan Pharmaceuticals, Inc.

19 COLONNADE WAY

STATE COLLEGE, PA, 16803

2064997284

SEC Filing

0001756479-26-000003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free